Decentralized clinical trials are gaining popularity and momentum, promoting a more flexible participant experience as a whole. However, decentralized trial modalities also present unique challenges.

This white paper aims to provide sponsors and institutional review boards (IRBs) with:

• A framework to understand ethical issues associated with decentralization
• Steps to take in deploying a decentralized trial